Skip to main content

Renal Week to Highlight Latest Developments in Kidney Disease

November 17, 2010 — The American Society of Nephrology (ASN)'s upcoming Renal Week 2010 is set to feature in-depth scientific exchange and groundbreaking research in basic, translational, and clinical sciences concerning kidney disease.

Key issues expected to generate vigorous discussion at the event include research on how physicians can improve patient outcomes on dialysis, genetic factors that might increase the incidence of end-stage renal disease in African Americans, and the way novel biomarkers contribute to the detection and care of acute kidney injury.

The Late-Breaking Clinical Trial session, one of the meeting's major events, will focus on the latest research developments pertaining to nephrology, said ASN program committee chair David Ellison, MD, FASN, in an interview with Medscape Medical News.

"Six groundbreaking trials of various treatment approaches to kidney disease will be presented in the Late-Breaking Clinical Trial session," said Dr. Ellison, who is the head of the Division of Nephrology and Hypertension at Oregon Health & Science University in Portland.

"The studies are all likely to influence how kidney disease is treated, and will have direct impact on patient care immediately," he predicted. They are:

  • Effects of Nocturnal Home Hemodialysis: The Frequent Hemodialysis Network Trials
  • Effect of Bardoxolone Methyl on Renal Function in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus
  • Results of the Multicenter [Focal Segmental Glomerulosclerosis] Clinical Trial in Children and Young Adults
  • Primary Safety and Efficacy Results from Four Phase 3 Randomized, Active-Controlled, Open-Label Studies of Hematide/Peginesatide Among CKD Dialysis and Nondialysis Patients
  • Prevention of Dialysis Catheter Lumen Occlusion With rt-PA vs Heparin (Pre-CLOT): A Randomized Trial
  • Should We Reduce [Low-Density-Lipoprotein] Cholesterol in Patients with Chronic Kidney Disease? The Results of the Study of Heart and Renal Protection (SHARP)

The conference will also feature talks by internationally recognized scientists who have been invited to present 4 State-of-the-Art Lectures, Dr. Ellison added.

"The talks will range from one by Harlan Krumholz [MD, SM, from Yale University, New Haven, Connecticut] discussing how to combine clinical practice and scholarship in pursuit of improved patient outcomes, to one by Elaine Ostrander [PhD, from the National Institutes of Health's National Human Genome Research Institute, Bethesda, Maryland] who will discuss the genetic basis of dog phenotypes ranging from size to coat color."

In addition, Michael J. Welsh, MD, from the University of Iowa in Iowa City and the Howard Hughes Medical Institute in New York City, will discuss his groundbreaking work entitled Cystic Fibrosis: Development and Lessons on the Pig Model, and Charles A. Dinarello, MD, from the Division of Infectious Diseases at the University of Colorado at Denver, will give a lecture entitled Interleukins and Human Disease.

A third major event of the conference will be the "Meeting-Within-a-Meeting" program, which will bring together physicians and scientists interested in specific topics. This year's sessions will focus on 4 key areas: epithelial transport and cell biology, renal immunology and transplantation, new insights into glomerular structure and function, and kidney development and stem cells.

One prominent issue expected to be addressed in lectures and discourse throughout Renal Week will be the changing role of reimbursement in dialysis, Dr. Ellison noted. "In light of changes in reimbursement for dialysis, we expect a great deal of attention to be focused on how to improve quality while reducing costs."

The conference is being held November 16 to 21 in Denver, Colorado, and organizers expect strong attendance from an international array of nephrology specialists.

"The meeting is truly international, with strong representation from Asia, Europe, and South America, as well as from the United States," Dr. Ellison said. "We expect approximately 13,000 people to attend the meeting, at least as many as have attended in the past."

Comments

Post a Comment

Popular posts from this blog

Low cost Bariatric Surgery in India for obese people with amazing cost saving for International Patients

Obesity now days being worlds most affecting health disorder and giving rise to a lot of various health hazards is the biggest threat to population through out the world. Our Low cost Bariatric surgery is the best proven method that results in a durable weight loss. Diets and other medical plans for weight loss have been shown to have very poor long term results and all with inability to maintain the weight loss. Long term weight loss without Bariatric surgery is only achieved by 5-10% of obese women, man and children. The people getting the Bariatric surgery throughout the world is the highest in western country itself it is estimated that around every year more than 200,000 bariatric surgeries are being performed in US itself still a lot of people needing the surgery  are unable to the get the surgery because of various factors such as the high end cost of the surgery, the surgery not being covered by the insurance or sometimes not getting the appointments. These have been...
23 comments
Read more

Yellow Fever Vaccination is given only between 10 am and 4 pm everyday. Appointment necessary!

Vaccination Appointment for International Travelers (VAIT) Yellow Fever Vaccination is given only between 10 am and 4 pm everyday. Mail a copy of your passport to info@hopehospital.com before your appointment date. Yellow fever : ·        Mandatory vaccination against yellow fever is carried out to prevent the importation of yellow fever virus into vulnerable countries. These are countries where yellow fever does not occur but where the mosquito vector and non-human primate hosts are present. Importation of the virus by an infected traveller could potentially lead to the establishment of infection in mosquitoes and primates, with a consequent risk of infection for the local population. In such cases, vaccination is an entry requirement for all travellers arriving from countries, including airport transit, where there is a risk of yellow fever transmission. If yellow fever vaccination is contraindicated for medical reasons, a medica...
Read more

Ideal medical tourism destination

Goa with it combination of super specialty hospitals and luxurious hotels, has been touted as an ideal medical tourism destination where ailing foreigners can combine a relaxing holiday with cheap but effective medical treatment. But the state is seeing a new trend: hitching onto the medico-leisure bandwagon are dentists who are offering their services at a fraction of the price their foreign clients would expect to pay at home.  Dr. Ambert Pimenta, for example catches the attention of prospective clients with a simple promise: get your dental treatment in Goa and holiday for free. His website ( www.goadentist.com ) says, "Yes as I promised, here is how you can make your holiday to Goa absolutely FREE ! Consider how much you pay in Europe or America ...are the long lines and frustrating long waits at an NHS dentist wearing you down ? Compare our pricing with that of any NHS service or private practice for that matter, we will leave the competition behind. The subsequent arithmetic...
3 comments
Read more